Eczema Free Forever™

Eczema Drug Shows Promising Phase 2 Results for Treatment of Eosinophilic Esophagitis – AJMC.com Managed Markets Network

Eczema Drug Shows Promising Phase 2 Results for Treatment of Eosinophilic Esophagitis
AJMC.com Managed Markets Network
This new study suggests that dupilumab's ability to quickly reduce inflammation, which makes it so effective in clearing up atopic dermatitis (eczema), appears to be at work in reversing type 2 inflammation in eosinophilic esophagitis. Dupilumab works

eczema – Google News

Eczema Free Forever™